Cytomembrane nanovaccines show therapeutic effects by mimicking tumor cells and antigen presenting cells
Cancer vaccines often fail to generate clinically relevant effects. Here, the authors generate a nanosized cytomembrane vaccine based on fusion between dendritic cells and cancer cells, and show them to activate anti-tumor immune responses via their antigen presenting and T-cell activating functions...
Guardado en:
Autores principales: | Wen-Long Liu, Mei-Zhen Zou, Tao Liu, Jin-Yue Zeng, Xue Li, Wu-Yang Yu, Chu-Xin Li, Jing-Jie Ye, Wen Song, Jun Feng, Xian-Zheng Zhang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/67ae9c77ce0a4c3384f5b7c2f11709b8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Antigen-Conjugated Silica Solid Sphere as Nanovaccine for Cancer Immunotherapy
por: Dong Y, et al.
Publicado: (2020) -
Improved proliferation of antigen-specific cytolytic T lymphocytes using a multimodal nanovaccine
por: Li B, et al.
Publicado: (2016) -
Anti-Tumor Efficacy of an Adjuvant Built-In Nanovaccine Based on Ubiquitinated Proteins from Tumor Cells
por: Huang F, et al.
Publicado: (2020) -
Prodigiosin found in Serratia marcescens y2 initiates phototoxicity in the cytomembrane
por: Wang,Fei, et al.
Publicado: (2013) -
CpG-Based Nanovaccines for Cancer Immunotherapy
por: Chen W, et al.
Publicado: (2021)